mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.33 |
2e-06 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.26 |
8e-06 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.27 |
4e-05 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-05 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.21 |
6e-05 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0001 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |